Rifaximin Treatment in Bloating Predominant Functional Bowel Disorders | MicrobiomeTrials← Back to trialsNCT07522255
Rifaximin Treatment in Bloating Predominant Functional Bowel Disorders
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-12Est. Completion: 2028-06
Enrollment target: 78 participants Locations- Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok Noi, Bangkok, Thailand
Other microbiome trials you might be interested in
Gastric Cancer (GC)Stomach Neoplasms
The goal of this clinical trial is to learn if transcutaneous electrical acupoint stimulation (TEAS) works to help peopl…
Qingdao, ChinaEst. completion Dec 1, 2026
Obesity & Overweight
Overweight and obesity are common metabolic disorders associated with increased risks of diabetes, cardiovascular diseas…
Nanchang, ChinaEst. completion Sep 1, 2028